Remus Pharmaceuticals L

REMUS NSE Healthcare Pharmaceuticals
₹1,911.30
-2.60%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does Remus Pharmaceuticals L belong to?
Remus Pharmaceuticals L operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.
What is the current share price of REMUS?
As of the latest available quote, REMUS traded at ₹1,911.30. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of REMUS?
Remus Pharmaceuticals L has a price-to-earnings (P/E) ratio of about 48.81. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of REMUS?
The market capitalisation of Remus Pharmaceuticals L is approximately ₹1,037 Cr.
Is Remus Pharmaceuticals L profitable?
For its latest reported financial year, Remus Pharmaceuticals L recorded a net profit margin of about 5.39%.
Does REMUS pay a dividend?
Remus Pharmaceuticals L currently has a dividend yield of about 0.05%.
What is the return on equity (ROE) of REMUS?
Remus Pharmaceuticals L has a return on equity (ROE) of about 12.20%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of REMUS?
Over the past 52 weeks, REMUS has traded between a low of ₹580.00 and a high of ₹987.50.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.